Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol Vaginal Tablets in Vulvar and Vaginal Atrophy
NCT02668796Phase 3Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Jan 2016
- Primary completion
- Sep 2016
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol in vulvovaginal atrophy (VVA), sponsored by Glenmark Pharmaceuticals. Started Jan 2016; status: completed.
02
Drugs
estradiol
03
Conditions
vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT02668796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668796.